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Abstract
Background: Women’s beliefs and representations of breast cancer (BC) and breast screening (BS) are salient
predictors for BS practices. This study utilized the health belief model (HBM) and common-sense model (CSM)
of illness self-regulation to explore factors associated with BS uptake in Malta and subsequently, to identify
the most important predictors to first screening uptake.
Methods: This cross-sectional survey enrolled Maltese women (n = 404) ages 50 to 60 at the time of their
first screening invitation, invited to the National Breast Screening Programme by stratified random sampling,
with no personal history of BC. Participants responded to a 121-item questionnaire by telephone between
June–September 2015. Data were analyzed using descriptive statistics, chi-square tests and logistic regression.
Results: There is high awareness of BC signs and symptoms among Maltese women (>80% agreement for
7 out of 8 signs), but wide variation about causation (e.g., germ or virus: 38.6% ‘agree’, 30.7% ‘disagree’).
‘Fear’ was the key reason for non-attendance to first invitation (41%, n = 66) and was statistically significant
across all subscale items (p < 0.05). Most items within HBM constructs (perceived barriers; cues to action;
self-efficacy) were significantly associated with first invitation to the National Breast Screening Programme,
such as fear of result (χ2 = 12.0, p = 0.017) and life problems were considered greater than getting mammography
(χ2 = 38.8, p = 0.000). Items within CSM constructs of Illness Representation (BC causes; cyclical cancer timeline;
consequences) were also significantly associated, such as BC was considered to be life-changing (χ2 = 18.0, p = 0.000)
with serious financial consequences (χ2 = 13.3, p = 0.004). There were no significant associations for socio-demographic
or health status variables with uptake, except for family income (χ2 = 9.7, p = 0.047). Logistic regression analyses showed
that HBM constructs, in particular perceived barriers, were the strongest predictors of non-attendance to first invitation
throughout the analyses (p < 0.05). However, the inclusion of illness representation dimensions improved the model
accuracy to predict non-attendance when compared to HBM alone (65% vs 38.8%).
Conclusions: Interventions should be based on theory including HBM and CSM constructs, and should target first BS
uptake and specific barriers to reduce disparities and increase BS uptake in Malta.
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Background
Breast cancer (BC) is the most prevalent cancer in
Europe [1], accounting for 28.8% of all female cancer
incidences [2] with 425,000 new cases diagnosed
yearly [3]. BC accounts for 21% of all female cancer
incidences in Malta with an average of 280 women
diagnosed each year, over the last decade [4].
Early detection of BC reduces morbidity and mortality,
resulting in more effective treatment regimens and
better survival rates [5]. Such mortality reductions are
largely dependent on interventions, such as breast self-
examination, clinical breast examination and screening [6].
Despite evidence that breast screening (BS) decreases
BC mortality rates by 25–30% [7–9], BC screening
rates remain suboptimal in many European countries
[10, 11]. Although European Guidelines for Quality
Assurance in BC [12] promote an acceptable target
screening rate of at least 70%, and ideally 75% of
eligible women [13], less than 60% of Maltese women
accepted their first screening invitation [14] from a
national breast screening programme, introduced in
2009 for women aged 50–60 years [13]. Since its
establishment in Malta, the Maltese Breast Screening
Programme (MBSP) routinely invites women free-of-
charge by letter every three years and has expanded
its cohort in its second screening round to include
women aged 61–66 years.
Reasons for non-attendance are well documented and
multifactorial [15, 16]. The extant literature suggests that
a number of factors influence BS uptake, namely: (1)
health beliefs [17–19], (2) illness representations [17, 20,
21], (3) knowledge of BC signs and symptoms, its causes
and consequences, and recommended BS practices [22,
23], (4) socio-demographic factors [22, 24, 25], and (5)
health status (medical factors) [17, 25–27].
Theoretical framework: The Health Belief Model and the
Common-Sense Model of Illness Representation
The Health Belief Model (HBM) was selected as one of
the theoretical models for the current study, as it is
widely used to identify associated variables with mam-
mography and guides the prediction of screening behav-
iours [17, 18]. The HBM consists of six constructs:
perceived susceptibility, perceived severity, perceived
benefits, perceived barriers, cues to action, and self-
efficacy [28, 29]. It proposes that the following factors
play an important role in an individual’s perception
about BS, such that women are more likely to perform
BS if: a) they feel susceptible (vulnerable) to BC or the
risks of contracting the disease (perceived susceptibility),
b) believe in the seriousness of BC and its consequences
for the individual (perceived severity), c) perceive more
benefits than barriers from undergoing mammography,
d) have higher confidence for obtaining a mammogram,
and e) if a cue to action is present [28].
HBM, however, only explains some variation in BS
behaviour [29], which is why the Common-Sense Model
(CSM) of self-regulation [or Self-Regulation Model
(SRM)], developed by Leventhal and colleagues in 1980s,
has been used to consider the cognitive and emotional
representations of an illness [17]. This study was also
informed by the CSM to understand how individual
symptoms and emotions influence one’s perception of
BC, such as its likely impact upon physical and psycho-
social functioning, and guide subsequent coping behav-
iour. Originally, illness representations comprised five
components: identity, cause, timeline, consequences, and
cure/control [17, 30]. These dimensions were further
differentiated to include a further four dimensions: time-
line cyclical; personal and treatment control; illness
coherence and emotional representations [31].
Although screening behaviours can be predicted by
knowledge, health beliefs and illness perceptions [17, 32],
only a small body of research has jointly explored the
latter to understand BS behaviour [17, 33], thereby limit-
ing opportunities to examine if certain cognitions explain
most of the variation in BS uptake. Furthermore, factors
influencing uptake to a first BS invitation may differ to
subsequent invitations, particularly since previous experi-
ence of BS is associated with future uptake [34]. Finally,
the determinants of BS behaviour have not been studied
in the Maltese population although determinants may not
be comparable across different countries [35].
The primary aims of the study were:
1. To describe Maltese women’s knowledge, health
beliefs and illness perceptions about breast cancer
and screening;
2. To identify the main reasons related to non-attendance
at the MBSP;
3. To determine if health beliefs, illness perceptions,
knowledge, socio-demographic factors and health
status are associated with uptake to first invitation at
the MBSP;
4. To determine the significant predictors to first
breast screening uptake.
‘Strengthening the Reporting of Observational
Studies in Epidemiology’ (STROBE) guidelines [36]
[see Additional file 1], have been used to present the
study findings in this article. This is the first study
of its kind in Malta; the findings could be used to
inform future strategies and interventions to improve
uptake in Malta, which as already highlighted, was
sub-optimal for first round screening [14]. We
hypothesized that there would be significant associa-
tions between health beliefs and illness perceptions,
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knowledge, socio-demographic factors, health status,
and BS uptake.
Methods
Study design
A cross-sectional survey of women’s uptake of first invi-
tation to the MBSP using validated tools to measure the
influence of health beliefs and illness representations
and using further questionnaires to measure knowledge
of BS practices, socio-demographic and health status
administered by telephone.
Setting
The study was carried out in Malta between June 2015
and September 2015. Since there is only one Breast
Screening centre (no mobile units), located in Malta’s
capital city, Valletta, all data was generated from one
computerized screening database and women were
contacted from the centre.
Participants
The inclusion criteria were: women aged 50–60 at the
time of their first screening invitation, residents in Malta
or Gozo with a valid identity card number, able to
communicate in English and Maltese, and with no severe
co-morbidities. Women were excluded if they had ever
been diagnosed with BC (n = 200), if they were invited
to the second screening cycle (n = 12,210), if registered
as deceased at the time of the sample selection (n = 71)
and if incorrect information existed at the MBSP
(n = 209) (Fig. 1).
Sample size and sampling technique
In order to ensure that the study sample was nation-
ally representative of the screening population and to
decrease the margin of error in the estimation,
women were selected by a stratified random sampling
technique, employed by strata i.e. district (geograph-
ical distribution), age and attendance/non-attendance
to the first BS invitation. According to the MBSP, the
target population was estimated to be 48,841 women
who were invited during the first screening cycle [37].
Following the exclusion of subjects (numbers in paren-
theses) in the sampling flowchart (Fig. 1), the eligible
population was calculated to be equal to 36,151 women. A
sample size of 404 women was determined using a 95%
confidence level and a 5% confidence interval. In order to
obtain this sample size, the following number of attendees
and non-attendees were randomly selected as follows:
n = 243 attendees [women’s reasons for attendance may
provide a better insight to why people do not turn up for
BS], and n = 161 non-attendees [this is representative
from the actual population as 58.7% of those invited
accepted their first invitation] [14]. Forty-five women
refused to participate in this study (due to two reported
personal reasons, i.e. lack of time due to work and family;
fearful to speak about the topic under investigation). All
45 women were free to provide their own reason for non-
participation. Content analysis of open-ended comments
on reasons for refusal was employed, and later categorised
and classified as being one of the above two reasons.
Women’s comments were typical reasons for refusals in
similar studies [38]. Due to the women’s refused participa-
tion, 449 women were eventually contacted in order to
reach the necessary quota for each strata (with 90%
response rate). Hence, the required total sample of 404
women was collected. Another 48 women were replaced
during data collection since they were found to be ineli-
gible during the telephone survey. All replacements were
carried out in a way so as not to lose any of the sample
representativeness of the population. Hence, replacements
were selected with the same demographics of the non-
respondent.
Data collection
The participant recruitment pathway is presented in
Fig. 1. Participants were recruited by telephone, by a
trained research assistant who requested initial verbal
consent. If the client agreed to participate, a brief
explanation of the study was provided by telephone.
Thereafter, a written information letter was posted to
women on that same day. Hence, women received
pre-notification letters to further inform the partici-
pant about the study’s aims, objectives and purpose,
thus allowing the participant adequate time to read
the information letter before further contact. Those
who refused participation were deemed to have
refused consent and were not contacted further.
Scheduled appointments were set at women’s most
convenient date and time (in around 7 days from first
phone call) so that participants would not to be
caught ‘off-guard’ when contacted by telephone, and
also so that the researcher could conduct a telephone
survey which was the chosen, feasible method for this
study. Telephone surveys have also been utilised
successfully in the extant literature [39, 40]. In cases
of non-response, three call-backs were performed on
different occasions, following which the researcher
moved on to contact other participants.
Subjects were provided with information regarding the
specific study aim, content and estimate time to respond
to the survey, and that no incentive would be provided.
Respondents were assured that all the collected informa-
tion would be processed anonymously and confidentially.
They were also informed that they could refuse to answer
any question or decline participation at any point. For
those participants who affirmed they were willing to
respond, verbal informed consent was obtained by
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telephone through the use of standard procedures and
guidelines [41]. Verbal consent is common practice when
conducting survey interviews or interventions by tele-
phone [39, 40, 42] and was chosen because it facilitates
comprehension of study objectives and questionnaire
items, and reduces the unnecessary burden entailed in a
written consent form [39].
Participant recruitment by the research assistant
was done manually, using paper format to record
verbal consent by ticking Yes/No and to schedule
appointments for the participants and the primary
investigator (DM). The telephone survey was carried
out by a single researcher (DM) and data entry was
carried out (DM) through the use of computer-
assisted technology through an online study tool (the
SurveyMonkey program). Subsequently, the data
were downloaded by the primary investigator (DM)
from the same program. Minor formatting adjust-
ments were made to the raw aggregate data in
Microsoft Excel, and then the data were exported
into the Statistical Package for the Social Sciences
(SPSS). This method of handling data significantly
decreased human error in the data entry process.
This procedure of data storage and handling was
secure, ensuring confidentiality of information pro-
vided by participants.
Fig. 1 Participant pathway and sampling flowchart (based on STROBE guidelines)
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Measures
The questionnaire was initially developed using
previously validated questionnaires (CHBMS-MS and
IPQ-R) [31, 43]. The CHBMS-MS and IPQ-R scales
were used after securing written permission from the
authors and were translated and adapted into the
Maltese language and tested for validity in a pilot study
involving 15 Maltese women [more information is avail-
able from the authors]. Our findings show overall posi-
tive correlation of the total inter-item correlation
(CHBMS-MS: 0.87, IPQ-R: 0.85) (p 0.001 respectively),
high Cronbach’s alpha (CHBMS-MS: 0.93, IPQ-R: 0.92),
overall acceptable internal consistency (CHBMS-MS:
0.69–0.83, IPQ-R: 0.75–0.93), and acceptable test-retest
reliability correlations: CHBMS-MS (Maltese: 0.62–0.76,
English: 0.61–0.84); IPQ-R (Maltese: 0.63–0.82, English:
0.61–0.91) (p 0.001 respectively). Hence, this version of
the instrument was used in this cross-sectional study.
The 121-item questionnaire is composed of four
sections:
1) 11 subscales for socio-demographic and health status
(20 items) related to age, residing district, education,
employment, marital status, family income, car
ownership/driving, illness/disability, having a GP,
breast condition, family history of BC or other cancer.
Response options were “yes”, “no” or a series of tick
boxes. Open questions were asked when it was believed
to be important that women could provide further
detail, for example, type of illness, breast condition or
cancer site.
2) 4 subscales for lifetime BS practices (17 items) that
were clustered in 4 subscales: lifetime mammography
use (4 items), attendance/non-attendance to first
round screening (8 items), re-attendance/intention
(4 items), knowledge about recommended screening
frequency (1 item). Most of the response options were
mostly designed to elicit “yes”, “no” or “unsure” answers.
Closed questions allowed women to respond to a series
of tick boxes.
3) 5 subscales for health beliefs (36 items) that were
clustered into: perceived susceptibility (3 items),
perceived benefits (6 items), perceived barriers
(13 items), cues to action (7 items) and self-efficacy
(7 items). All items had 5 response options ranging
from: 1 = ‘strongly disagree’ to 5 = ‘strongly agree’.
Reverse scoring (r) was performed for only one item
‘There is no possibility of getting breast cancer’ so that
higher values would indicate greater possibility.
4) 7 subscales for illness perceptions (48 items) that
were clustered into: breast cancer identity (8 items),
causal scale (18 items), cancer timeline: acute/chronic
(2 items), cyclical (1 item), consequences (8 items),
curability/controllability (personal control - 3 items;
treatment control - 3 items), illness coherence
(2 items), and emotional representations (3 items). All
items had 5 response options ranging from:
1 = ‘strongly disagree’ to 5 = ‘strongly agree’.
Ethical considerations
Ethics approval was obtained from the School Research
Ethics Committee at the University of Stirling (SREC14/
15-Paper No.18v4) and by the Maltese Health Ethics
Committee (HEC 02/2015). After securing written
permission from the Chief Executive Officer, data were
obtained from the MBSP and was computer generated
from the local screening register.
Variable definitions
A first invitation was defined as the first (initial) time a
woman is invited to the MBSP and either attends or
does not attend for the screening mammogram. Modify-
ing factors include socio-demographic and health status
variables (some of which were confirmed from women’s
health records from the screening database), and struc-
tural variables such as knowledge of screening frequency
and of the disease. These variables were collected from
the survey administered retrospectively from the time of
the first screening invitation.
Data analysis
Data entry and statistical analysis were performed using
SPSS® version 21.0 under direct instruction and guidance
of an expert statistician. Descriptive and inferential
statistics, such as percentages, frequencies, means, stand-
ard deviations and confidence intervals, were used to
present the basic statistics in relation to the demographics,
knowledge, health beliefs and illness perception variables.
Tests for associations (Chi-square test: to determine
significant associations between one categorical variable
and another categorical variable) were applied to investi-
gate the associations of health beliefs, illness representa-
tions, knowledge, socio-demographic factors and health
status with uptake to MBSP. Binary logistic regression
modelling, using the “Backward-elimination” method, was
performed to identify the significant predictors for BS
uptake. The unstandardized coefficients, standard error,
the Wald value, p-values, Odds Ratios (ORs) and 95%
confidence intervals (95% CIs) were calculated for each
logistic regression model. The level of accuracy was
included in the final outcome of the model. Missing data
was minimal and reported in Table 1. Statistical signifi-
cance was established at p < 0.05 for all analyses.
Piloting the data collection method
A pilot study was conducted with a random sample of
15 women of different age groups to assess and ascertain
the practicalities of conducting the tool by telephone. In
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order to reduce bias, a random selection of participants
was computer generated from the computerized data-
base of the MBSP; hence, attendance for first round
screening was ascertained from programme records. A
similar approach to the larger study for ‘selection’ and
‘recruitment’ can be similarly referred to in the partici-
pant pathway (Fig. 1). These women were contacted by a
research assistant and those who agreed to participate
were introduced to the researcher. A convenient time
was arranged with each participant in order for the
researcher to conduct the pilot survey by telephone.
Verbal informed consent was sought from all 15 partici-
pants. The results from the pilot study showed that the
tool was practical and feasible to conduct by telephone
and that no methodological changes were required.
Women participating in the pilot study were not
included in the larger study. The time for scale comple-
tion had a median of 25 min (range, 15–45 min).
Results
Sample characteristics
The sample characteristics (n = 404) are presented in
Table 1. Women were aged between 50 to 60 years at
the time of the programme’s first screening round,
with a mean age of 54.6 years ±2.8 years (SD). The
majority were married (86.9%, n = 351), housewives
(77%, n = 311), had up to a secondary education level
(75.7%, n = 306) and more than half (60.3%, n = 244)
were from below average income families (lower than
€16,113). Although the majority owned a family car
(83.7%, n = 338), only 43.8% (n = 177) could drive.
An illness, disability or condition was reported by
45.8% of women (n = 185) and 2.5% (n = 10) had
Table 1 Sample Characteristics (n = 404)
Characteristics Mean SD N %
Age (year)
50 20 5.0
51 45 11.1
52 42 10.4
53 48 11.9
54 56 13.9
55 44 10.9
56 29 7.2
57 44 10.9
58 27 6.7
59 37 9.2
60 12 3.0
54.62 2.79
Education level
No schooling 1 0.3
Primary level 67 16.6
Secondary level 306 75.7
Tertiary level 30 7.4
Occupation
Pensioner 5 1.2
Housewife 311 77.0
Employee 88 21.8
Status
Single 16 4.0
Married 351 86.9
Separated/Divorced 13 3.2
Widowed 24 5.9
Family income
Less than €10,737 102 25.3
€10,737 – €16,113 142 35.2
€16,114 – €23,563 20 5.0
€23,564 – €33,966 14 3.5
Greater than €33,966 1 0.3
Prefer not to say 125 30.9
Own a car
Yes 338 83.7
No 66 16.3
Drive
Yes 177 43.8
No 227 56.2
Any illness, disability or condition
Yes 185 45.8
No 219 54.2
Table 1 Sample Characteristics (n = 404) (Continued)
Family physician (GP)
Yes 377 93.3
No 27 6.7
Frequency of GP visit
Only when I have a problem 358 88.6
Once a month 6 1.5
More than once a year 16 4.0
Once a year 1 0.2
Missing 23 5.7
Lumpy breasts
Yes 30 7.4
No 374 92.6
Relatives or close friends had cancer
Yes 330 81.7
No 68 16.8
Prefer not to say 6 1.5
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cancer (other than BC). Furthermore, 81.7% (n = 330)
had relatives or close friends with cancer [6.7%
(mother with BC) and 21.3% (close friend with BC)].
The majority (93.3%, n = 377) reported having a
named family physician (GP); however, 88.6%
(n = 358) of the total sample visited a GP only when
they had a problem. Furthermore, nearly 70% of
women in this study reported that they were not
encouraged by their GP to attend to breast screening.
Knowledge of breast screening frequency and breast
cancer
The majority of women were knowledgeable of the
recommended screening frequency to varying degrees
(Table 2): 46.3% (n = 187) indicated yearly mammo-
grams; 3.7% (n = 15): every 1.5 years; 43.3%
(n = 175): every 2–3 years; 6.2% (n = 25) were
unsure). BC identity scores were reported by above
80% of women for the majority of the sub-scale items
(7 out of 8 items) (Table 3). However, there was wide
variation for knowledge of causes and risk factors of
BC among Maltese women (Table 3). Hereditary pre-
disposition to the disease was the most commonly
reported risk factor, followed by smoking, altered
immunity and pollution. Misconceptions concerning
risk factors of BC were found [e.g. a germ or virus
(38.6% ‘agree’, 30.7% ‘disagree’; accident or injury
(47.5% ‘agree’; 39.1% ‘disagree’)].
Health beliefs and illness perceptions
Women’s health beliefs and illness perceptions are
presented in Table 4. Subscale scores were retrieved as the
mean of items (i.e. those items with which respondents
are most in agreement, though a disagreement answer for
barrier items represents a more positive result). In general,
higher percentage scores indicate higher agreement
among participants for perceived benefits of mammog-
raphy (79.7%), self-efficacy (77.7%) and cues to action
(76.6%), while lower scores indicate lower agreement
among women for perceived barriers (45.1%). There was
also higher agreement with emotional representations
(82.0%), personal control items (78.7%), BC identity
(76.5%) and cyclical cancer timeline perceived (72.0%),
while lower agreement for BC causes (62.4%) and cancer
timeline (acute/chronic) (61.0%).
When comparing health beliefs and illness percep-
tions among attendees and non-attendees (Tables 5–6),
the majority agree that the possibility of developing BC
in their lifetime is high (M = 4.0, SD = 0.3) and believe
in early detection through screening (M = 4.2, SD = 0.5).
Each item in the ‘perceived barrier’ subscale was scored
by respondents with the highest level of uncertainty,
such that 6 out of 13 items had a mean score of 2.5–3.5
(Table 5).
This study found that a large number of participants
had higher emotional representations when they think
about BC, such that they get anxious (M = 3.6, SD = 1.1),
feel afraid (M = 4.3, SD = 0.7) and worried (M = 4.4,
SD = 0.7), they believe that BC has major consequences
on a patient’s life (M = 4.3, SD = 0.6), and more specific-
ally, their whole life would change (M = 4.2, SD = 0.6).
The course of the BC pathway is believed to be
dependent on their actions (M = 3.9, SD = 0.4).
Reasons for non-attendance to first breast screening
invitation
When non-attendees were asked to further identify reasons
for non-attendance to first round screening at the MBSP
(i.e. respondents were allowed to mention more than one
reason), the main reported reason was fear (41.0%, n = 66),
of which sub-categories included ‘fear of result’ (20.5%;
n = 33), ‘fear of pain’ (10.6%; n = 17), ‘fear of an unknown
procedure’ (depicting knowledge gap) (6.2%; n = 10), ‘fear of
radiation’ (3.7%, n = 6) and ‘embarrassment’ (8.1%; n = 13).
Some women had also opted for the service elsewhere
(38.5%, n = 62) or had never received an invitation (13.7%;
n = 22). Practical reasons were mentioned by 8.7% (n = 14)
of non-attendees, which included ‘busy at work’ or ‘home’,
‘transport issues’, ‘on vacation’ and ‘being ill’.
Associations between health beliefs and uptake to first
screening invitation
The variables related to HBM constructs were compared
with attendance and non-attendance to the first round
screening at the MBSP (Table 5). In general, the majority
of the HBM constructs showed statistical significance as
follows:
Perceived benefits
Women who feel good about themselves when getting a
mammogram (χ2 = 16.7, p = 0.001) were more likely to
attend their first screening invitation. On the other hand,
non-attendees believe less than attendees that BS will
help to detect a lump early before it can be felt
(χ2 = 7.8, p = 0.051).
Table 2 Women’s Knowledge of breast screening frequency
(n = 404)
n %
Knowledge about recommended
breast screening frequency
Every year 187 46.3
Every year and a half 15 3.7
Every 2–3 years 175 43.3
Every 4–5 years 2 0.5
Unsure 25 6.2
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Perceived barriers
Although there was no significant association between
anxiety and initial screening uptake, fear was found to
be statistically significant across all subscale items
(p < 0.05). Non-attendees expressed fear of a cancer
diagnosis (χ2 = 12.0, p = 0.017), fear of the unknown
procedure (χ2 = 31.9, p = 0.000), fear of radiation
(χ2 = 16.6, p = 0.001), consider mammography to be
embarrassing (χ2 = 13.6, p = 0.009) and other problems
in life to be greater than getting a mammogram
(χ2 = 38.8, p = 0.000), and were more undecided on
whether the mammography procedure is painful
(χ2 = 39.0, p = 0.000). On the other hand, attendees are
more in disagreement with the statement: ‘they are not
old enough to have a mammogram periodically’
(χ2 = 22.6, p = 0.000) and have less fear or distrust in
the medical team (χ2 = 38.3, p = 0.000).
Cues to action
Women attend more if advised by their GP (χ2 = 13.6,
p = 0.004) and if someone close to them had BC
(χ2 = 13.8, p = 0.008), but do not attend more if advised
by their relatives or friends (χ2 = 2.0, p = 0.576).
Attendees are more in agreement that hearing about BC
and BS in the media or news makes them think about
getting a mammogram (χ2 = 15.7, p = 0.000), and simi-
larly reminder letters (χ2 = 15.4), phone calls or text
messages (χ2 = 15.4), and educational talks (χ2 = 16.9)
help them to get a mammogram done (p = 0.001
respectively).
Table 3 Women’s Knowledge on breast cancer identity and causes (n = 404)
Breast cancer identity scores, n (%)
Disagree/Strongly Disagree Undecided Agree/Strongly Agree
The presence of a lump or thickening in the breast 5 (1.2) 26 (6.4) 373 (92.3)
Nipple discharge 3 (0.7) 54 (13.4) 347 (85.9)
Sudden nipple retraction 2 (0.5) 64 (15.8) 338 (83.7)
Change in shape or appearance of the nipple 2 (0.5) 29 (7.2) 373 (92.3)
Breast swelling, dimpling, redness or soreness of the skin 3 (0.7) 66 (16.3) 335 (82.9)
Skin changes of the breast 3 (0.7) 67 (16.6) 334 (82.7)
A sudden change in breast size 5 (1.2) 52 (12.9) 347 (85.9)
Aching breasts 40 (9.9) 114 (28.2) 250 (61.9)
Causes of breast cancer scores, n (%)
Disagree/Strongly Disagree Undecided Agree/Strongly Agree
Stress or worry 152 (37.6) 95 (23.5) 157 (38.9)
Your mental attitude 262 (64.9) 94 (23.3) 48 (11.8)
Family problems or worries 171 (42.3) 82 (20.3) 151 (37.4)
Overwork 281 (69.6) 59 (14.6) 64 (15.8)
Your emotional state 257 (63.6) 76 (18.8) 71 (17.6)
Your personality 262 (64.9) 94 (23.3) 48 (11.8)
Hereditary - it runs in the family 5 (1.2) 10 (2.5) 389 (96.3)
Diet or eating habits 121 (30.0) 61 (15.1) 222 (55.0)
Poor medical care in the past 98 (24.3) 90 (22.3) 216 (53.4)
Your own behaviour 174 (43.1) 172 (42.6) 58 (14.3)
Ageing 142 (35.1) 63 (15.6) 199 (49.3)
Smoking 47 (11.6) 39 (9.7) 318 (78.7)
Alcohol 80 (19.8) 60 (14.9) 264 (65.3)
A germ or virus 124 (30.7) 124 (30.7) 156 (38.6)
Pollution in the environment 65 (16.1) 49 (12.1) 290 (71.8)
Altered immunity 43 (10.6) 69 (17.1) 292 (72.3)
Chance or bad luck 205 (50.7) 37 (9.2) 162 (40.1)
Accident or injury 158 (39.1) 54 (13.4) 192 (47.5)
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Self-efficacy
Attendees also tend to agree more that they can arrange
other things in life to get a mammogram (χ2 = 13.1,
p = 0.011), such as finding a place to get it done
(χ2 = 10.9, p = 0.028), arranging an appointment
(χ2 = 12.1, p = 0.016) and transportation (χ2 = 13.1,
p = 0.011), and also paying for it if they need to
(χ2 = 10.3, p = 0.036).
Associations between illness perceptions and uptake to
first screening invitation
Illness perception constructs were compared with
attendance and non-attendance to the first screening in-
vitation to the MBSP (Table 6). In general, Chi-square
tests showed no statistical significance for BC identity
items, acute/chronic cancer timeline, personal and treat-
ment control, illness coherence and emotional represen-
tation items with first screening uptake.
Causes of breast cancer
In general, no significant association was found for
most causal variables. However, attendees were more
in agreement that BC could be hereditary (χ2 = 13.4,
p = 0.004) and considered one’s own behaviour to
cause BC (χ2 = 10.0, p = 0.018), while non-attendees
were more undecided whether one’s emotional state
or personality cause BC (χ2 = 19.0, p = 0.000).
Cancer timeline (cyclical)
Attendees agree more than non-attendees that a patient
with BC gets better and worse (χ2 = 11.1, p = 0.026).
Consequences
Attendees consider more that BC has major consequences
on a patient’s life (χ2 = 14.2, p = 0.003), has serious eco-
nomic and financial consequences (χ2 = 13.3, p = 0.004)
and is life-changing (χ2 = 18.0, p = 0.000). On the other
hand, non-attendees are more undecided whether BC
would strongly affect the way others see them (χ2 = 14.9,
p = 0.005) and consider the chances of living a long life to
decrease (χ2 = 9.4, p = 0.024).
Associations between sociodemographic and health
status, knowledge of breast screening frequency and
uptake to first screening invitation
There were no significant associations for demographic
factors or health status variables with first screening
uptake, except for family income (χ2 = 9.7, p = 0.047).
Non-attendees were the most unsure of the recom-
mended screening frequency (χ2 = 13.9, p = 0.003).
Predictors of uptake to first screening invitation
Different groups of variables and constructs were
incorporated into seven logistic regression models and the
‘backward-elimination’ method was applied to every model
to identify the significant predictors of BS uptake (Table 7).
Table 4 Instrument scoring: the percentage and mean scores for Health Beliefs and Illness Perceptions
Health Beliefs
aSubscale Minimum Maximum Mean Score Percentage Score
Perceived Susceptibility 3 15 9.6 64.0%
Perceived Benefits 6 30 23.9 79.7%
Perceived Barriers 13 65 29.3 45.1%
Cues to action 7 35 26.8 76.6%
Self-Efficacy 7 35 27.2 77.7%
Illness Perceptions
aSubscale Minimum Maximum Mean Score Percentage Score
Breast Cancer Identity 8 40 30.6 76.5%
Causes of Breast Cancer 18 90 56.2 62.4%
Cancer Timeline: Acute/Chronic 2 10 6.1 61.0%
Cancer Timeline: Cyclical 1 5 3.6 72.0%
Consequences 8 40 28.3 70.8%
Personal Control 3 15 11.8 78.7%
Treatment Control 3 15 9.9 66.0%
Illness Coherence 2 10 7 70.0%
Emotional Representations 5 15 12.3 82.0%
aAll subscale items were grouped according to their respective subscale. Each subscale item had 5 response options ranging from 1 = ‘strongly disagree’ to
5 = ‘strongly agree’
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Table 5 Comparison of Health Beliefs between attendees and non-attendees
When you received your invite to the Breast Screening programme,
did you attend?
Yes No Total Chi-Square testa
Health Beliefs Mean SD Mean SD Mean SD χ2 p-value
There is no possibility of getting breast cancer (r) 1.9 0.7 2.0 0.7 2.0 0.7 4.3 0.367
Your chances of getting breast cancer are high 3.7 0.7 3.6 0.8 3.6 0.8 7.1 0.130
There may be the possibility of developing breast cancer in your
lifetime
4.0 0.3 4.0 0.4 4.0 0.3 1.7 0.645
When you get a mammogram, you feel good about yourself 4.0 0.4 3.9 0.5 4.0 0.5 16.7 0.001*
When you get a mammogram, you do not worry as much about
breast cancer
3.8 0.8 3.6 0.8 3.7 0.8 2.8 0.423
Having a mammogram will help you find lumps early in your breasts 4.2 0.4 4.1 0.5 4.2 0.5 7.8 0.051
If you find a lump through a mammogram, the treatment for breast
cancer may not be as bad
4.0 0.4 4.0 0.3 4.0 0.4 3.3 0.349
Having a mammogram will decrease your chances of dying from
breast cancer
4.0 0.4 4.0 0.3 4.0 0.3 6.2 0.103
Having a mammogram will help you find a lump before it can be
felt by yourself or a health professional
4.0 0.5 4.0 0.4 4.0 0.5 0.6 0.899
Having a routine mammogram would make you anxious about
breast cancer
2.7 1.0 2.9 1.0 2.8 1.0 7.1 0.070
Having a routine mammogram would make you worry 2.7 1.0 2.9 1.0 2.8 1.0 3.9 0.416
You fear having a mammogram because you might find out that
something is wrong
2.9 1.0 3.2 1.0 3.0 1.1 12.0 0.017*
You fear having a mammogram because you do not know the
procedure or what to expect
2.2 0.6 2.5 0.9 2.3 0.8 31.9 0.000*
You fear having a mammogram because you know someone
(family or friend) with breast cancer
2.6 1.1 2.9 1.1 2.7 1.1 7.1 0.132
It is embarrassing for you to have a mammogram 2.4 0.8 2.7 1.0 2.5 0.9 13.6 0.009*
Undergoing mammography will be painful or uncomfortable 3.4 1.0 3.3 0.9 3.3 1.0 39.0 0.000*
Having a mammogram is time consuming 1.2 0.4 1.3 0.6 1.3 0.5 7.2 0.067
You are discontent with Breast Screening personnel as they have
been rude to you
1.2 0.5 n/a n/a 1.2 0.5 n/a n/a
You have fear or distrust in the medical team 1.7 0.7 2.2 0.9 1.9 0.8 38.3 0.000*
Having a mammogram would expose you to unnecessary radiation 2.2 0.6 2.5 0.8 2.3 0.7 16.6 0.001*
You have too many other problems in your life than to get a
mammogram done
1.6 0.6 2.0 0.8 1.7 0.7 38.8 0.000*
You are not old enough to have a mammogram periodically 1.7 0.5 1.9 0.4 1.8 0.5 22.6 0.000*
If your GP advises you to attend for a mammogram, you will attend 4.3 0.6 4.0 0.7 4.2 0.7 13.6 0.004*
If your relatives or friends advise you to attend for a mammogram,
you will attend
3.4 1.0 3.4 1.0 3.4 1.0 2.0 0.576
If someone close to you has been diagnosed with breast cancer,
you will attend for a mammogram
4.2 1.0 3.9 1.0 4.1 1.0 13.8 0.008*
Hearing about breast cancer and breast screening in the media or
news makes you think about getting a mammogram
3.8 0.7 3.5 0.9 3.6 0.8 15.7 0.000*
Reminder letters would help you to get a mammogram 4.0 0.4 3.8 0.7 3.9 0.5 15.4 0.001*
Reminder phone calls or text messages would help you to get a
mammogram
4.0 0.4 3.8 0.7 3.9 0.5 15.4 0.001*
Routine educational talks regarding breast cancer awareness would
help you to get a mammogram
3.8 0.7 3.5 0.9 3.6 0.8 16.9 0.001*
You feel confident that if you had a mammogram done, any
abnormalities in your breasts will be detected
3.7 0.6 3.6 0.7 3.7 0.6 2.2 0.697
You can arrange other things in your life to get a mammogram 4.2 0.6 4.0 0.7 4.1 0.7 13.1 0.011*
In case you need a mammogram, you will find a place to get it done 4.2 0.5 4.1 0.5 4.2 0.5 10.9 0.028*
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Model 1 (Demographics) and Model 2 (Health status)
All items related to demographic variables were incorpo-
rated in a logistic regression model (Model 1) and health
status items were incorporated into Model 2. Both
demographics and health status variables were found to
be non-important predictors of BS uptake, such that for
both models, non-attendance was not predicted and
none of the variables were found to be significantly
different.
Model 3 (Health Belief items)
All items related to HBM were incorporated in a
logistic regression model (Model 3). Five variables
were found to be good predictors of BS uptake:
‘distrust in medical team’, ‘fear of unknown procedure’,
‘other life problems’, ‘relatives and friends advice’ and
‘reminder letters’ (Table 7). For this model, attend-
ance was predicted with an accuracy of 88.5% and
non-attendance was predicted with 38.8%.
Model 4 (Illness Perception items)
All IPQ-R variables were incorporated into one logistic
regression model (Model 4). Seven variables were found
to be good predictors: ‘hereditary’, ‘pollution’, ‘a patient
with BC goes through cycles in which her illness gets
better and worse’, ‘BC has major consequences on a
patient’s life’, ‘if you had BC, your whole life would
change’, ‘if you developed BC, the chances of living a long
life would decrease’ and ‘BC makes you feel afraid’
(Table 7). The accuracy for this model was found to be
83.5% for attendance and 37.3% for non-attendance.
Model 5 (Significant predictors from Models 3 and 4)
The above significant predictors from both models 3
and 4 were incorporated into a new single model
(Model 5) and backward-elimination was applied on
these 12 variables (five Health Beliefs and seven
Illness Perception variables). The final model retained
nine significant predictors, without excluding any of
the Health Belief variables, hence showing that Health
Beliefs are more significant predictors than Illness
Perceptions. The model accuracy, when combining
both scores, improved to 53.8% for non-attendance
and 84.8% for attendance.
Model 6 (All individual Health Belief and Illness Perception
items)
When all items related to Health Beliefs and Illness Per-
ceptions were incorporated into one model (Model 6),
21 variables were found to be significantly different. The
accuracy of the model improved again to 85.2% for
attendees and 65% accuracy for non-attendees.
Model 7 (All 14 constructs)
When the 14 constructs (not individual items) related
to Health Beliefs and Illness Perceptions were used to
construct a logistic regression model (Model 7),
‘perceived barriers’, ‘cancer timeline (cyclical)’ and
‘illness coherence’ were found to be the significant
predictors, of which the ‘perceived barriers’ construct was
the strongest predictor. However, the accuracy for predict-
ing the non-attendees was found to be 42.2%, which is
inferior when compared to Model 5. Moreover, when
removing the ‘perceived barriers’ variable from the latter
model, the accuracy to predict non-attendance decreased
sharply from 42.2% to 14.9%.
Our findings reveal that ‘perceived barriers’ is the most
important construct to describe the variance between
attendees and non-attendees. This result is further
echoed in Model 5, where three predictors (from all the
other predictors) are all related to perceived barriers.
The above logistic regression analyses show that, although
Health Beliefs are the most important predictors of BS
uptake, the inclusion of Illness Perception items into one
logistic regression model is important to improve the
accuracy of the model (Model 5 vs Model 3).
Discussion
For the first time, this study aimed to explore factors related
to Maltese women’s BS behaviours, as well as their know-
ledge, health beliefs and illness perceptions related to BC
and BS, providing answers as to why more than 40% of
eligible women did not attend their first MBSP invitation.
Table 5 Comparison of Health Beliefs between attendees and non-attendees (Continued)
You can make an appointment for a mammogram 4.2 0.5 4.1 0.6 4.2 0.5 12.1 0.016*
You can arrange transportation to get a mammogram 4.2 0.5 4.1 0.6 4.2 0.6 13.1 0.011*
You can talk to people at the breast screening centre about your
concerns
4.1 0.7 n/a n/a 4.1 0.7 n/a n/a
You can find a way to pay for a mammogram if you need to 4.2 0.5 4.1 0.5 4.2 0.5 10.3 0.036*
*Significant at α = 0.05
(r) = reverse scored
aChi-square test was applied for all health beliefs; hence the categorical answers were used to apply this test for association. For each question, respondents were
asked to select a number between 1 and 5, where 1 = strongly disagree and 5 = strongly agree.
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Table 6 Comparison of Illness Perceptions between attendees and non-attendees
When you received your invite to the Breast Screening programme, did you attend? Yes No Total Chi-Square testa
Illness Perception Mean SD Mean SD Mean SD χ2 p-value
The presence of a lump of thickening in the breast 3.9 0.4 3.9 0.3 3.9 0.3 5.5 0.141
Nipple discharge 3.9 0.4 3.8 0.4 3.9 0.4 3.8 0.286
Sudden nipple retraction 3.9 0.4 3.8 0.4 3.8 0.4 5.8 0.121
Change in shape or appearance of the nipple 3.9 0.3 3.9 0.3 3.9 0.3 1.7 0.630
Breast swelling, dimpling, redness or soreness of the skin 3.8 0.4 3.8 0.4 3.8 0.4 2.6 0.463
Skin changes of the breast 3.8 0.4 3.8 0.4 3.8 0.4 2.1 0.555
A sudden change in breast size 3.8 0.4 3.9 0.4 3.9 0.4 0.4 0.950
Aching breasts 3.5 0.7 3.5 0.7 3.5 0.7 2.9 0.578
Stress or worry 3.0 0.9 3.0 0.8 3.0 0.9 3.9 0.140
Your mental attitude (e.g. thinking about life negatively) 2.5 0.7 2.5 0.7 2.5 0.7 6.0 0.111
Family problems or worries 3.0 0.9 2.9 0.9 3.0 0.9 3.5 0.178
Overwork 2.5 0.8 2.4 0.7 2.5 0.8 4.1 0.249
Your emotional state (e.g. feeling down, lonely, anxious, empty) 2.5 0.8 2.6 0.8 2.5 0.8 19.0 0.000*
Your personality 2.4 0.7 2.5 0.7 2.5 0.7 6.6 0.087
Hereditary - it runs in the family 4.6 0.6 4.4 0.6 4.5 0.6 13.4 0.004*
Diet or eating habits 3.3 0.9 3.2 0.9 3.3 0.9 5.6 0.131
Poor medical care in the past 3.3 0.8 3.3 0.8 3.3 0.8 2.4 0.489
Your own behaviour 2.7 0.7 2.8 0.7 2.7 0.7 10.0 0.018*
Ageing 3.1 0.9 3.1 0.9 3.1 0.9 4.9 0.087
Smoking 3.7 0.7 3.6 0.7 3.7 0.7 3.0 0.399
Alcohol 3.5 0.8 3.4 0.8 3.5 0.8 0.1 0.948
A germ or virus 3.0 0.8 3.1 0.8 3.1 0.8 3.7 0.160
Pollution in the environment 3.7 0.8 3.5 0.8 3.6 0.8 6.1 0.108
Altered immunity 3.6 0.7 3.6 0.7 3.6 0.7 1.5 0.683
Chance or bad luck 3.0 1.0 2.8 0.9 2.9 1.0 5.8 0.214
Accident or injury 3.1 0.9 3.1 0.9 3.1 0.9 1.7 0.782
Breast cancer will last a short time 2.8 0.7 2.9 0.7 2.8 0.7 4.2 0.241
Breast cancer is likely to be permanent rather than temporary 3.3 0.8 3.2 0.8 3.3 0.8 1.5 0.481
A patient with breast cancer goes through cycles in which her illness gets
better and worse
3.7 0.7 3.4 0.7 3.6 0.7 11.1 0.026*
Breast cancer has major consequences on a patient's life 4.3 0.6 4.2 0.5 4.3 0.6 14.2 0.003*
Breast cancer will not have much effect on your life 1.5 0.7 1.6 0.7 1.5 0.7 11.8 0.019*
Breast cancer would strongly affect the way others see you 3.3 1.0 3.3 0.9 3.3 0.9 14.9 0.005*
Breast cancer has serious economic and financial consequences 3.9 0.6 3.7 0.7 3.8 0.6 13.3 0.004*
Breast cancer would strongly affect the way you see yourself as a person 4.1 0.5 4.0 0.6 4.1 0.6 0.7 0.875
Breast cancer would threaten a relationship with your husband or partner 3.1 0.9 3.0 0.9 3.1 0.9 2.2 0.699
If you had breast cancer, your whole life would change 4.3 0.7 4.1 0.6 4.2 0.6 18.0 0.000*
If you developed breast cancer, the chances of living a long life would decrease 4.0 0.5 4.0 0.3 4.0 0.4 9.4 0.024*
There is a lot which you can do to control the symptoms if Breast Cancer occurs 3.9 0.4 3.9 0.4 3.9 0.4 2.6 0.629
The course of Breast Cancer will depend on your actions 4.0 0.4 3.9 0.3 3.9 0.4 5.9 0.118
Your actions will have an effect on the outcome of Breast Cancer 4.0 0.3 4.0 0.2 4.0 0.3 5.9 0.118
There is no treatment that will help to improve Breast Cancer 2.0 0.6 2.0 0.5 2.0 0.5 5.8 0.211
The treatment provided will be effective in controlling or curing Breast Cancer 4.0 0.3 3.9 0.3 4.0 0.3 1.8 0.615
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Knowledge
Study findings confirm the wide variation in knowledge
level of Maltese women about causes of BC and its
related risk factors, though good awareness of BC signs
and symptoms were reported, such as nipple discharge
and sudden nipple retraction. Women’s limited know-
ledge about BC and BS practices has been identified in a
consistent body of literature [22, 32, 44, 45]. For
instance, Grunfeld et al. [46] showed that only 38% of
people were aware that nipple retraction was a sign of
BC, and awareness of risk factors was even lower.
Notably, local misconceptions (e.g., one’s own behaviour,
personality, emotional state, germ or virus, accident or
injury could cause BC) also corroborate findings in older
studies (e.g., hitting or bumping the breast), which is
consistent with women’s beliefs in other societies with
different cultures such as the Philippines, Korea, Saudi
Arabia and Australia [45–47].
Since relevant knowledge has been emphasized as a
screening compliance predictor [48, 49] or a screening
barrier [50], we hypothesized that there would be a
significant association between knowledge and BS
uptake in Malta. Our findings support this hypothesis
since Maltese women who have a lack of awareness
regarding screening recommendations, guidelines and
BC related risk factors are more likely not to attend and
this may prove difficult for women to perceive their risk
[22]. Communicating risk information to the general
public makes knowledge an essential element of health
promotion, disease prevention and screening interven-
tions [51]. Despite the vast array of worldwide initiatives,
an overlap exists between knowledge, health beliefs and
illness perceptions; the knowledge construct operational-
ized in BS studies does not often include identifications
of specific beliefs [48]. Hence, in order for a woman to
attend for her BS appointment, she must perceive the
actual threat of BC, believe that cancer can be avoided
by BS, and that she is capable of accessing the unit,
which may include remembering her appointment,
driving to or be driven to the unit, and not be afraid of
the test [52].
Reasons to non-attendance
Fears, negative expectation of the screening experience and
embarrassment were among the main barriers to BS in this
study, similarly reported to act as barriers to attendance
and re-attendance worldwide [15, 16, 45, 49, 53–59]. Minor
practical barriers to non-attendance reported in our study
(such as lack of time, transportation issues) are also reiter-
ated in previous studies [16, 56, 58, 59], justifying local
transportation accessibility improvements and reduction of
logistical barriers [32].
Health beliefs and illness perceptions
Significant associations were mainly found for health beliefs
about BS and BC i.e. the perceptions of the behaviour (bar-
riers, self-efficacy, cues to action), while weaker associations
were found for the perceptions of the illness i.e. significant
associations for certain illness perception items (causes,
cyclical cancer timeline, consequences) with uptake. Non-
attendance to BS was related to more perceived barriers,
less perceived benefits, lower self-efficacy and cues to ac-
tion, and to the representations of the causes, consequences
and timeline of BC. In contrast to HBM, perceived suscep-
tibility was not significantly associated with first screening
attendance in this study; a finding which corroborates
results in previous studies [60–62] and contrasts others
[18, 23, 62, 63]. One explanation for this finding may be
due to women’s lack of knowledge about BC and BS [60],
such that improving women’s risk assessment of developing
BC may increase uptake rates. Our findings are in agree-
ment with previous studies where positive association with
perceived self-efficacy and having BS was found [62, 63].
This implies that attendees feel confident that they can
arrange other things in their life to get a mammogram.
However, self-efficacy was not the most important predictor
for the decision to undergo screening in Malta. This result
complies with a study in Cyprus [64] and contrasts the
findings by Orji et al. [29].
It has also been reported that if a woman perceives mam-
mography benefits to be higher than perceived barriers, she
is more likely to adhere to BS [23, 58, 65]. However, the
benefits subscale was not the most significant component
Table 6 Comparison of Illness Perceptions between attendees and non-attendees (Continued)
The negative effects of Breast Cancer can be prevented or avoided by
the treatment given
4.0 0.3 3.9 0.3 3.9 0.3 5.5 0.241
You have a clear picture and understanding of Breast Cancer 3.8 0.6 3.8 0.6 3.8 0.6 0.7 0.873
Breast Cancer is a mystery to you 3.2 1.0 3.2 1.0 3.2 1.0 3.7 0.455
You get anxious when you think about Breast Cancer 3.6 1.1 3.7 1.1 3.6 1.1 2.6 0.464
Breast Cancer makes you feel afraid 4.3 0.7 4.3 0.6 4.3 0.7 1.7 0.645
You get worried when you think about Breast Cancer 4.4 0.7 4.4 0.6 4.4 0.7 1.4 0.502
*Significant at α=0.05
aChi-square test was applied for all illness perceptions; hence the categorical answers were used to apply this test for association. For each question, respondents
were asked to select a number between 1-5, where 1 = strongly disagree and 5 = strongly agree.
Marmarà et al. BMC Public Health  (2017) 17:416 Page 13 of 19
Table 7 Comparison of Illness Perceptions between attendees and non-attendees
B SE Wald P-value OR 95% CI Model Accuracy YES Model Accuracy NO
Model 1: Demographics 100% 0%
Drive -0.361 0.207 3.047 0.081 0.697 0.465, 1.045
Constant 0.979 0.342 8.172 0.004 2.661
Model 2: Health Status 100% 0%
Breast condition 0.174 0.265 0.430 0.512 1.190 0.708, 1.998
Constant 0.081 0.492 0.027 0.869 1.085
Model 3: Health Beliefs 88.5% 38.8%
Distrust in medical team −0.573 0.153 14.051 0.000 0.564 0.418, 0.761
Fear of unknown procedure −0.409 0.153 7.120 0.008 0.664 0.492, 0.897
Other life problems −0.693 0.195 12.630 0.000 0.500 0.341, 0.733
Relatives or friends’ advice −0.363 0.130 7.745 0.005 0.696 0.539, 0.898
Reminder letters 0.660 0.238 7.678 0.006 1.934 1.213, 3.083
Constant 2.336 1.091 4.585 0.032 10.335
Model 4: Illness Perceptions 83.5% 37.3%
Hereditary 0.456 0.185 6.072 0.014 1.578 1.098, 2.268
Pollution 0.290 0.134 4.682 0.030 1.336 1.028, 1.738
Illness gets better and worse 0.312 0.153 4.154 0.042 1.366 1.012, 1.844
Major consequences in life 0.420 0.195 4.640 0.031 1.522 1.039, 2.231
Whole life would change 0.509 0.201 6.442 0.011 1.664 1.123, 2.466
Living long decreases −0.685 0.298 5.290 0.021 0.504 0.281, 0.904
Fear of breast cancer −0.363 0.176 4.264 0.039 0.695 0.492, 0.983
Constant −3.375 1.494 5.106 0.024 0.034
Model 5: Health Beliefs and Illness Perceptions 84.8% 53.8%
Distrust in medical team −0.676 0.162 17.468 0.000 0.509 0.371, 0.699
Fear of unknown procedure −0.612 0.166 13.629 0.000 0.542 0.392, 0.751
Other life problems −0.669 0.206 10.544 0.001 0.512 0.342, 0.767
Relatives or friends’ advice −0.476 0.140 11.610 0.001 0.621 0.473, 0.817
Reminder letters 0.687 0.251 7.470 0.006 1.987 1.214, 3.251
Pollution 0.479 0.151 10.060 0.002 1.615 1.201, 2.172
Illness gets better and worse 0.396 0.167 5.656 0.017 1.486 1.072, 2.061
Whole life would change 0.855 0.221 14.924 0.000 2.351 1.524, 3.626
Living long decreases −0.890 0.336 7.016 0.008 0.411 0.212, 0.793
Constant 0.113 1.742 0.004 0.948 1.120
Model 6: Health Beliefs and Illness Perceptions 85.2% 65.0%
Fear of unknown procedure −0.742 0.194 14.633 0.000 0.476 0.325, 0.696
Embarrassing −0.320 0.149 4.600 0.032 0.726 0.542, 0.973
Distrust in medical team −0.808 0.176 21.149 0.000 0.446 0.316, 0.629
Other life problems −0.735 0.234 9.843 0.002 0.479 0.303, 0.759
Relatives or friends’ advice −0.529 0.153 11.965 0.001 0.589 0.437, 0.795
Reminder letters 0.795 0.290 7.536 0.006 2.215 1.255, 3.907
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associated with BS in Malta unlike in other studies [53, 66].
It was the strong negative association between perceived
barriers and screening uptake which was mainly identified
in this study, similar to the findings of other studies involv-
ing American asymptomatic women [67], Israeli women
[68] and other populations [61–63, 69]. It was predomin-
antly fear that was found to be statistically significant across
all subscale items. This is evidenced by women who do not
attend for mammography in other countries because they
perceive greater fear of BC [70–72]. A cancer diagnosis
seems to be associated with a negative physical, psycho-
logical and social impact on Maltese women’s ability to
cope with the outcomes of the disease, which can have a
profound effect on their way of life: an economical and
financial impact, altered perception of others and oneself,
altered relationship with their husband/partner, and that
diagnosis may lead to mortality. This is noticeable in other
findings [14, 71–73]. It is also likely that the fear of knowing
someone with cancer is related to the cultural impact it
would have on a woman’s life or social local networks [72].
This consistent fear across populations stems from the be-
lief that there is little an individual can do to alter fate (fa-
talism) or prevent cancer [73]. Therefore, non-attendees
may be more pessimistic of early BC detection and the ef-
fectiveness of subsequent treatment, and may perceive BC
as being uncontrollable, chronic and highly symptomatic
with avoidance and denial coping strategies [74].
Helping to manage barriers associated with cancer and
screening could be one of the main tasks addressed by in-
terventions to increase uptake, for example through the use
of patient navigators alongside access to care [75] and the
identified recommendations from a physician, health care
providers, family member and personal communication
with other women which have been proven to be of greater
importance than external cues [26, 27, 59, 76]. However,
our findings are evidence that many women are not en-
couraged by their GP to attend to BS and would attend
more if advised. This is in agreement with a previous study
where screening tests are advised at suboptimal rates [59].
Similarly, in a cross-sectional study among Arab women in
Qatar, only one quarter of the women interviewed said their
doctors had discussed BC with them [77]. It is important to
provide a local context for the lack of GP recommendation
and to take into account unique aspects of the Maltese
health care service. Although the state health system and
private GPs provide primary health care in Malta, patients
are not affiliated with a regular primary care general practi-
tioner or group practice [78]. Besides, there exists an extent
of private purchase of screening outside public health ser-
vices [78]. However, little is known in Malta regarding the
Table 7 Comparison of Illness Perceptions between attendees and non-attendees (Continued)
Arrange appointment 1.133 0.506 5.020 0.025 3.106 1.153, 8.372
Pay for mammography −1.669 0.580 8.286 0.004 0.188 0.06, 0.587
Stress or worry −0.940 0.419 5.044 0.025 0.39 0.172, 0.887
Family problems 0.839 0.405 4.292 0.038 2.314 1.046, 5.118
Overwork 0.539 0.216 6.262 0.012 1.715 1.124, 2.616
Personality −0.548 0.240 5.235 0.022 0.578 0.361, 0.924
Hereditary 0.533 0.231 5.342 0.021 1.704 1.084, 2.677
Pollution 0.500 0.170 8.698 0.003 1.649 1.183, 2.299
Change or bad luck 0.432 0.140 9.568 0.002 1.54 1.171, 2.024
Illness gets better and worse 0.398 0.185 4.629 0.031 1.489 1.036, 2.141
Economic consequences 0.647 0.223 8.438 0.004 1.91 1.234, 2.955
Whole life would change 0.755 0.245 9.493 0.002 2.128 1.316, 3.441
Living long decreases −1.177 0.373 9.956 0.002 0.308 0.148, 0.64
Depends on your actions 0.856 0.409 4.381 0.036 2.354 1.056, 5.246
Your actions effects outcome −1.094 0.552 3.933 0.047 0.335 0.114, 0.987
Constant 0.384 3.083 0.016 0.901 1.468
Model 7: The 14 constructs 84.4% 42.2%
Perceived barriers −0.121 0.022 31.731 0.000 0.886 0.849, 0.924
Cancer timeline cyclical 0.432 0.154 7.893 0.005 1.54 1.139, 2.081
Illness coherence 0.249 0.100 6.179 0.013 1.283 1.054, 1.561
Constant 0.623 0.895 0.484 0.487 1.864
B unstandardized coefficients; SE standard error; OR odds ratio; CI confidence interval
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true supporting network of women’s care pathway to date
[79]. These issues, coupled with negative women’s represen-
tations of BC and perceived barriers to BS may have re-
sulted in non-attendance to first screening invitation at the
MBSP.
Sociodemographic factors and health status
Our findings also demonstrate that women with a lower
family income tend to attend less to screening. There is
consistent evidence that lower household income demon-
strates lower utilization of BS in various countries [16, 54,
80], which also seems to be associated with late stage BC
presentation in London [81]. However, in regression ana-
lyses, our results revealed that the demographic and health
status variables were poor and insignificant predictors of
screening uptake and hence, do not provide strength to
predict non-attendees. Similarly, sociodemographic factors
do not appear to constitute strong predictions of non-
attendance in various studies [57], which is why other
determinants such as health beliefs and illness perceptions
need to be explored within populations because of their im-
portance in stimulating positive health behaviours [53].
Predictors to first breast screening uptake
Previous studies have demonstrated that beliefs about BC
and BS are important predictors of uptake [17, 19, 53, 65,
73]. In our regression analysis, health belief constructs
emerged as the strongest and most significant predictors of
attendance and non-attendance, and that perceived barriers
were the strongest predictor to describe the variance be-
tween attendees and non-attendees (p < 0.05). This fits well
with previous literature, where interventions tailored after
the Health Belief Model (HBM) were more effective in
increasing BS uptake than those that were not (6 studies
OR = 2.51, OR = 1.27, p < 0.001) [76]. Limited evidence for
the effectiveness of interventions based on other models
was found [82].
We found only one Greek study which similarly incorpo-
rated both HBM and CSM to explore health beliefs and ill-
ness perceptions [17], though this theoretical framework
was related to lifetime mammography use as opposed to
our study regarding BS uptake in an organised programme.
However, their results similarly showed that illness percep-
tion dimensions did not prove to be significant predictors
of mammography lifetime use. There may be a number of
alternative explanations for the non-significant associations
and the less significant predictions exhibited by illness
representation dimensions and screening uptake in our
study. Hagger and Orbell [74] hypothesized that coping
may just mediate the effect of illness cognitions on the out-
comes of an illness (e.g., psychological well-being, social,
and role functioning). This may be due to women’s focus
on illness representations (‘mental representation’) as such,
rather than on coping strategies (such as obtaining a
screening mammogram or visiting a doctor) which, in turn,
may possess a different set of diverse and multiple charac-
teristics which IPQ-R does not tackle (e.g., specific beliefs
about mammography risks). Therefore, it seems that it is
the HBM constructs related to response efficacy (expecting
that a particular health action will result in an outcome,
such as undertaking mammography screening), self-
efficacy, and utility beliefs (believing that taking a certain
action would be worthwhile to reduce BC susceptibility or
severity, if the disease did occur, while perceived benefits
would outweigh perceived barriers to undertaking health
actions) that are significant predictors to BS uptake, rather
than the IPQ-R dimensions. However, the CSM is the only
model which seriously considers the role of emotions in
response to illness [83], although even here ‘emotions’ are
often inadequately operationalised as ‘anxiety’, worry about,
or ‘fear’ of symptoms. On the other hand, the HBM is con-
sidered a weak predictor of behaviour change as it does not
include the formation of an intention to change behaviour
as a precursor to behavioural change, does not accommo-
date social and environmental influences or past behaviour,
and assumes that human decision-making are rational [84].
In response to each model’s limitations, a combination of
the two may determine behaviour likelihood [84, 85] and as
shown in this study, their combination provided improved
prediction of non-attendance (i.e. prediction of non-
attendance improved significantly from 38.8% to 65.0%
when combining all significant predictors). This suggests
that interventions could be aimed to incorporate various
dimensions of both models.
Limitations
Although these data can be generalizable to other
screening programmes with a similar population, such
as Mediterranean populations, this study has some
limitations. First, a temporal relationship between ex-
posure and outcome cannot be established because the
study was cross-sectional thus excluding causal associa-
tions. Second, the study’s retrospective design may have
had an impact on the recall of events. Third, it was not
possible to capture the data of repeat mammograms at
another facility as this was not recorded on the screen-
ing database at the time of study. Such data would show
more accurately women’s adherence to screening guide-
lines [86] by using multiple points of service. Hence,
future research should take into account the type of
screening programme and a clear distinction of the type
of mammography (screening or diagnostic mammography),
since women’s accuracy and consistency in reporting mam-
mography experiences sharply declines with an increased
number of lifetime mammograms [87]. Fourth, data
collected might be affected by recall or social-desirability
response bias i.e. having performed mammography,
whether in the organized screening programme or as
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opportunistic screen due to its well-publicized recommen-
dation by media and clinicians [17], thus amplifying the re-
call bias effects.
Additional research is required to test the interactions of
HBM and CSM components in multivariate models to test
threat representations and coping mechanisms. Further re-
search to measure health beliefs and illness perceptions be-
fore and after screening could help to clarify the value of
HBM and CSM in explaining the beliefs and perceptions of
BC risks. Additionally, a longitudinal study design could
provide a better understanding of the psychological and
emotional pathways and processes involved in how individ-
uals form beliefs and risk perceptions of a particular health
threat to better understand the factors underpinning health
behaviours and reduce BC risk. Further research is war-
ranted to determine whether uptake to first screening invi-
tation is a significant predictor of subsequent screening in
Malta.
Conclusions
The present study showed that there is high awareness of
BC signs and symptoms among Maltese women, but wide
variation in knowledge about causes of BC and its related
risk factors. Non-attendees were the most unsure of BS rec-
ommended practices and had higher emotional barriers. In-
terventions to increase BC screening uptake in Malta
should address health beliefs, in particular perceived bar-
riers such as fear, since these emerged as the strongest pre-
dictors of uptake throughout the analyses. However, those
interventions that also address illness representations, such
as causes, consequences and cyclical timeline of BC, may
increase their effectiveness since these were also found to
be associated with BS uptake. The CHBMS-MS and IPQ-R
variables that contributed most to the regression model
were perceived barriers, cues to action and self-efficacy,
causes of BC, cancer cyclical timeline, BC consequences
and personal control. The findings of this study indicate
that it was the combination of both HBM and CSM con-
structs which provides improved prediction of non-
attendance. To our knowledge, this is an innovative finding
in BS research. This study provides valuable information to
healthcare providers, researchers, screening leads and public
health educators as the findings can aid to design culturally
sensitive interventions to improve screening behaviours.
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